Teva Pharmaceuticals is found liable in the opioid crisis : NPR
Teva Pharmaceuticals CEO on the Covid-19 vaccine rollout in Israel
Teva Pharmaceuticals, NY reach opioid lawsuit settlements worth $523M - Top Class Actions
Teva Pharmaceuticals (@TevaUSA) / Twitter
Teva Pharmaceuticals (@TevaUSA) / Twitter
Articles with Teva Pharmaceuticals, Inc.
Teva Pharm expects to start paying U.S. opioid settlement in 2023 - CEO | MarketScreener
Acino and Teva sign deal to complete acquisition of Mepha's ...
Teva responds to Mylan backlash with planned launch of generic EpiPen | Healthcare IT News
Teva taps former Biogen exec Richard Francis as CEO - News
Teva Pharmaceuticals - Wikipedia
We see a stable U.S. market place for our generics, says Teva Pharma CEO
Teva: A Complete Overview (NYSE:TEVA) | Seeking Alpha
Teva Launches Two Digital Inhalers in the U.S., AirDuo® Digihaler® (fluticasone propionate and salmeterol) Inhalation Powder and ArmonAir® Digihaler® (fluticasone propionate) Inhalation Powder
Teva Pharmaceuticals: Making Quality Health Care Accessible
Teva introduces QVAR RediHaler inhalation aerosol in US - Pharmaceutical Technology
Teva's flagship drug Austedo scores new approval at the FDA
Teva Pharmaceuticals (@TevaUSA) / Twitter
Teva Becomes First Pharmaceutical Company to Execute Sustainability-Linked Bond Tied to Both Climate and Access to Medicine Targets | News Direct
Teva, with a $4.25B opioid settlement in hand, eyes return to growth by 2027 | Fierce Pharma
Teva Tries to Put an End to the Opioid Wars - WSJ
Teva Pharmaceuticals (@TevaUSA) / Twitter
Teva CEO Schultz likely won't renew employment contract: reports
Teva Pharmaceutical meets forecasts, but 2023 outlook disappoints | Reuters
Teva Releases Generic EpiPen in Limited Doses in the U.S. - WSJ
Teva Announces Appointment of Richard Francis as President and CEO | Business Wire
